GUTS (STOCKS)
Fractyl Health, Inc. Common Stock
$0.680000
+0.018000 (+2.72%)
Prev close: $0.662000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Harith Rajagopalan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $108.76M
- Employees
- 109
- P/E (TTM)
- -0.61
- P/B (TTM)
- -63.11
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.12 | $-0.14 | +0.0177 | +12.85% |
|
Mar 2026 (Q1)
|
$-0.13 | $-0.16 | +0.0332 | +20.34% |
|
Dec 2025 (Q4)
|
$-0.07 | $-0.18 | +0.1136 | +61.87% |
|
Sep 2025 (Q3)
|
$-0.71 | $-0.32 | -0.3877 | -120.29% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$19.76M |
| Operating Expenses | $85.89M |
| Selling, General, and Administrative Expenses | $22.53M |
| Research and Development | $63.36M |
| Operating Income/Loss | -$85.89M |
| Income/Loss From Continuing Operations After Tax | -$105.65M |
| Income/Loss From Continuing Operations Before Tax | -$105.65M |
| Net Income/Loss | -$105.65M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$105.65M |
| Net Income/Loss Available To Common Stockholders, Basic | -$105.65M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.88 |
| Diluted Earnings Per Share | -$0.88 |
| Basic Average Shares | 403,370,522 |
| Diluted Average Shares | 403,370,522 |
| Assets | $81.98M |
| Current Assets | $49.60M |
| Noncurrent Assets | $32.37M |
| Fixed Assets | $1.85M |
| Other Non-current Assets | $30.53M |
| Liabilities | $83.64M |
| Current Liabilities | $15.74M |
| Accounts Payable | $1.01M |
| Other Current Liabilities | $14.73M |
| Noncurrent Liabilities | $67.91M |
| Equity | -$1.67M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$1.67M |
| Liabilities And Equity | $81.98M |
| Net Cash Flow From Operating Activities | -$82.43M |
| Net Cash Flow From Operating Activities, Continuing | -$82.43M |
| Net Cash Flow From Investing Activities | $34.39M |
| Net Cash Flow From Investing Activities, Continuing | $34.39M |
| Net Cash Flow From Financing Activities | $107.29M |
| Net Cash Flow From Financing Activities, Continuing | $107.29M |
| Net Cash Flow | $59.25M |
| Net Cash Flow, Continuing | $59.25M |
| Comprehensive Income/Loss | -$105.65M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$105.65M |
| Other Comprehensive Income/Loss | $0.00 |